Additionally, the m5C score was negatively associated with the activities of many critical anticancer immunity cycles, including CD8 T cell recruitment; B-cell recruitment; cancer antigen presentation, priming and activation; myeloid-derived suppressor cell recruitment; neutrophil recruitment; natural killer cell recruitment; and Th1 cell recruitment (Figure 6C; Supplementary Table 14). This evidence concerns the gene CD8A and cancer.